GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancerRaksha R. Bhat, Meghana V. Trivedi, C. Kent Osborne et al.|Breast Cancer Research and Treatment|2018Cited by 25
Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysisArturo B. Ramirez, Meghana V. Trivedi, Raksha R. Bhat et al.|BMC Cancer|2019Cited by 24
Abstract 319: Role of GPR110 on tumorigenesis and metastasis in HER2+ breast cancer in the context of anti-HER2 drug resistanceDebashish Sahay, Meghana V. Trivedi, Raksha R. Bhat et al.|Cancer Research|2016Cited by 2
Abstract P2-02-07: Collection, high-resolution imaging, and single cell isolation of circulating tumor cells from patient derived xenograft models using the AccuCyte® – CyteFinder® systemAB Ramirez, EP Kaldjian, Debashish Sahay et al.|Cancer Research|2016Cited by 1
Targeting GPR110 in HER2-Overexpressing Breast CancersRachel Schiff, Meghana V. Trivedi, Debashish Sahay et al.|Unknown|2015Cited by 0